Trial Profile
Efficacy of Preoperative Intravenous Iron Isomaltoside in Colorectal Cancer Surgical Patients With Iron Deficiency Anaemia Compared to Standard Care: a Pilot Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 17 Jul 2020 Status changed from recruiting to completed.
- 23 Jun 2019 Planned End Date changed from 30 Jun 2020 to 30 Jun 2021.
- 23 Jun 2019 Planned primary completion date changed from 30 Jun 2019 to 30 Jun 2020.